Skip to content

Clinical Study On The Transcutaneous Electrical Stimulation Treatment For Chronic Stable Angina

Clinical Study On The Transcutaneous Electrical Stimulation Treatment For Chronic Stable Angina

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16010128
Enrollment
Unknown
Registered
2016-10-02
Start date
2016-09-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stable Angina

Interventions

Group A :Transcutaneous electrical stimulation at bilateral PC6 based on the standard medication treatmen of cardiovascular department
Group B:standard medication treatmen of cardiovascular department

Sponsors

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patient should meet the western medicine diagnostic standard of coronary artery disease and traditional Chinese medicine diagnostic standard of chest pain.It should be found that the stenosis of coronary artery trunk reaches to 50%-70% by the DSA or CTCA test. The ECG showed abnormal ST-T changes. Ultrasonic cardiogram showed left ventricular dysfunction. If a patient who meets one of above three condition can be chosen. 1. Conform to the ACC/AHA diagnostic standard of chronic stable angina; 2. Aged 35 to 80 years, male or female; 3. Onset time of 3 months and above, and weekly episodes greater than or equal to 2 times in nearly one month; 4. The patient sign the informed consent; The patient who is meet all the four itmes will be enrolled in the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactation woman, and the woman who have reproductive requirements in recently half year should be excluded; 2. The patients, who combine with serious cardiovascular diseases, for example acute coronary syndrome (including acute myocardial infarction and unstable angina), serious arrhythmia(serious atrioventricular block, ventricular tachycardia, supraventricular tachycardia with abnormal hemodynamic changes, and frequent premature beats, especially ventricular premature beats), atrial fibrillation, primary cardiac myopathy, and valvular heart disease, should be excluded; 3. The patients with uncontrolled hypertension (BP=160/100mmHg) and diabetes(FBG=10.0mmol/L, PBG=15mmol/L)should be excluded; 4. The patients, who combine with serious primary brain, liver, kidney, and hemopoietic system diseases, acute diseases, infectious diseases, and malignant tumor, should be excluded; 5. The patients with mental diseases should be excluded; 6. The patients with bleeding and allergy tendency should be excluded; 7. The patients, who were accepted the acupuncture treatment for cardiovascular diseases in the latest three months, should be excluded; 8. The patients, who participate in other clinical trials, should be excluded. The patient meet one of the nine items should be excluded.

Design outcomes

Primary

MeasureTime frame
Change of Angina score;

Secondary

MeasureTime frame
Seattle Angina Scale score;Change of ST decrease in ECG;Adverse events;

Countries

China

Contacts

Public ContactQingqiao Song

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

sqqbj@126.com+86 13911873540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026